By Amanda Gardner
EmpowHer's HealthDay Reporter
SATURDAY, May 31 (HealthDay News) -- Patients diagnosed with pancreatic cancer -- which historically carries a grim prognosis -- nearly doubled their overall survival when the cancer drug Gemzar was used after surgery, new research shows.
Unfortunately, only about 15 percent of pancreatic cancer patients are even candidates for surgery.